Combined Synopsis/SolicitationPosted Sep 18, 2026·Responses due Sep 23, 2026

2D High-Density Multi-Electrode Array Electrophysiology Platform

FDA · FDA OFFICE OF ACQ GRANT SVCS

Stage
Open solicitation
NAICS
334516
Value
Not stated
Solicitation
RFQ_CBER-2026-135968
Set-aside
No Set aside used
PSC
6640
Place
Not stated
Contact
Iris Johnson (Iris.Johnson1@fda.hhs.gov)
CSV Email

Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.

Where this opportunity stands

Every notice posted under solicitation RFQ_CBER-2026-135968 in this department, oldest first.

Early notice
None posted
Solicitation
  • Sep 14, 2026
    Combined Synopsis/Solicitation
    Open
  • Sep 18, 2026 · this notice
    Combined Synopsis/Solicitation
Award
Not yet. Too few past cases at this agency to estimate timing (6 found; 10 needed).

Next steps for this stage

Standard steps for the notice type; not advice about this buyer.

  • Decide bid or no bid before the response deadline.
  • Look at the past winners for likely competitors and teaming partners.
  • Follow the opportunity to hear about amendments and the award.

What the notice says

The purpose of this amendment is to provide clarification regarding the Government�s final acceptance timeframe. No further questions will be addressed regarding this solicitation. The solicitation closing date and time will not be extended. **************************************************************************************************************************************************** The U.S. Food and Drug Administration (FDA), Office of Acquisitions and Grants Services (OAGS), is issuing this combined synopsis/solicitation for the acquisition of a 2D High-Density Multi-Electrode Array (ME… (show all)

A) Electrophysiology Platform, including required hardware, software, accessories, initial consumables, installation, system verification, calibration, training, warranty coverage, and preventative maintenance option periods. This solicitation is issued as a Request for Quotation (RFQ) for commercial products and services. This announcement constitutes the only solicitation; quotations are being requested, and a separate written solicitation will not be issued. This requirement is being solicited on an unrestricted basis. NAICS Code: 334516 � Analytical Laboratory Instrument Manufacturing PSC: 6640 � Laboratory Equipment and Supplies Set-Aside: None � Unrestricted Basis for Award: Lowest Price Technically Acceptable (LPTA) Award will be made to the responsible offeror whose quotation is determined to be technically acceptable and represents the lowest evaluated price. Technical acceptability will be evaluated on a pass/fail basis against the minimum requirements identified in the solicitation and attached Requirements Document. Quotations that fail to meet any mandatory minimum requirement may be determined technically unacceptable and will not be considered for award. The solicitation includes a base requirement consisting of the equipment and associated supplies/services, a two-year warranty from final Government acceptance, and three one-year option periods for preventative maintenance and repair services. The solicitation is subject to the Trade Agreements Act. Offerors shall provide the country of origin for all offered end products and complete all applicable representations and certifications. Questions: All questions regarding this solicitation shall be submitted in writing no later than September 17, 2026, at 10:00 AM Eastern Time. Questions received after the deadline may not be answered. Responses to questions may be posted through an amendment to the solicitation. Quotation Due Date: Quotations shall be submitted no later than September 23, 2026, at 10:00 AM Eastern Time. Offerors shall submit a complete quotation that includes, at a minimum, technical documentation demonstrating compliance with the solicitation requirements, completed technical compliance information, pricing for the base requirement and all option periods, warranty information, delivery lead time, country of origin for all offered items, UEI, and confirmation of active SAM.gov registration. All solicitation documents, attachments, amendments, and Government responses to questions will be posted to SAM.gov. Offerors are responsible for monitoring SAM.gov for amendments or other updates to this solicitation.

Who won similar work

24 award notices on SAM.gov in the last 24 months. Match: Same agency (FDA), any industry: a loose match.

Loose match: same agency, any industry. Read the titles before treating these as competitors.

WinnerAwardsValueLast
Please_See_Spreadsheet Silver Spring MD 20993 USA3$153.2MOct 8, 2026
DCT, INCORPORATED1$52.8MSep 15, 2026
TRANQUIL CLINICAL AND RESEARCH CONSULTING SERVICES LLC1$50.0MSep 16, 2025
NATI-NVE Support Services, LLC1$49.0MMay 21, 2026
HARVARD PILGRIM HEALTH CARE INC1$31.7MMar 30, 2026
TOXICOLOGIC PATHOLOGY ASSOCIATES INC1$26.1MSep 15, 2025
IHRC, INCORPORATED1$14.5MSep 16, 2026
VITALANT Scottsdale AZ 85258 USA1$10.0MSep 8, 2025
WE PHARMA, INC.1$4.0MSep 11, 2026
THE BIONETICS CORP1$2.8MJul 21, 2025

Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in.

Latest awards

Competitive landscape

For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.

  • 0 of these past winners lobbied Food & Drug Administration (FDA) since 2024 (0 filings)
  • 0 of their lobbyists list a past Food & Drug Administration (FDA) job
  • No corporate PAC money from them to the overseeing committees since 2024
  • 0 foreign-agent (FARA) registrations
See who and the source records with Pro

Policy around it

Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.

  • 0 bills named on the past winners' lobbying filings
  • 129 rules from the department in the last 12 months
  • 0 executive orders naming the agency in the last 12 months
See who and the source records with Pro

Market

For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards.

  • 0 of the past winners are listed companies
  • 0 insider buys and 0 insider sells at them in the last 90 days
See who and the source records with Pro

Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.

Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.